Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis.

× No keyword cloud information.

10 in total

Review 1. Pulmonary complications of tumor necrosis factor-targeted therapy.

Authors: Krishna Thavarajah; Peggy Wu; Elisa J Rhew; Anjana K Yeldandi; David W Kamp
Journal: Respir Med Date: 2009-02-07 Impact factor: 3.415

2. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register.

Authors: W G Dixon; K L Hyrich; K D Watson; M Lunt; D P M Symmons
Journal: Ann Rheum Dis Date: 2010-05-05 Impact factor: 19.103

3. Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.

Authors: Ruy Carrasco; Judith A Smith; Daniel Lovell
Journal: Paediatr Drugs Date: 2004 Impact factor: 3.022

4. Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment.

Authors: Hirofumi Taki; Yukio Kawagishi; Koichiro Shinoda; Hiroyuki Hounoki; Reina Ogawa; Eiji Sugiyama; Kazuyuki Tobe
Journal: Rheumatol Int Date: 2009-12 Impact factor: 2.631

5. Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.

Authors: Tamao Nakashita; Katsutoshi Ando; Norihiro Kaneko; Kazuhisa Takahashi; Shinji Motojima
Journal: BMJ Open Date: 2014-08-14 Impact factor: 2.692

Review 6. Rheumatoid arthritis-associated interstitial lung disease.

Authors: Joshua J Solomon; Kevin K Brown
Journal: Open Access Rheumatol Date: 2012-03-05

Review 7. [Treatment of rheumatic diseases and pulmonary toxicity].

Authors: J Schreiber; U Müller-Ladner
Journal: Pneumologe (Berl) Date: 2018-09-25

Review 8. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors: Sherine E Gabriel; Kaleb Michaud
Journal: Arthritis Res Ther Date: 2009-05-19 Impact factor: 5.156

Review 9. Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Authors: Shunsuke Mori
Journal: Clin Med Insights Circ Respir Pulm Med Date: 2015-09-08

10. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models.

Authors: Qiu-Lan Ma; Cansheng Zhu; Marco Morselli; Trent Su; Matteo Pelligrini; Zhengqi Lu; Mychica Jones; Paul Denver; Daniel Castro; Xuelin Gu; Frances Relampagos; Kaitlin Caoili; Bruce Teter; Sally A Frautschy; Gregory M Cole
Journal: Front Immunol Date: 2020-10-16 Impact factor: 7.561

10 in total